Cardiol Therapeutics (CRDL) Current Leases (2020 - 2026)

Cardiol Therapeutics has reported Current Leases for 7 years, with the latest figure at $29016.6 in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 21.56% year-over-year to $29016.6; the trailing twelve-month figure through Mar 2026 stood at $29016.6 (up 21.56% YoY), and the FY2025 full-year result was $27498.1, up 16.37% from the prior year.
• Current Leases for Q1 2026 stood at $29016.6, up from $27498.1 in the prior quarter.
• The five-year high for Current Leases was $38148.4 in Q1 2023, with the low at $11611.5 in Q4 2023.
• Historically, Current Leases has averaged $27340.8 across 5 years, with a median of $26831.0 in 2025.
• Annual changes were most pronounced in 2023 — Current Leases tumbled 68.76% — and 2024, when it soared 103.5%.
• Cardiol Therapeutics' Current Leases stood at $37164.5 in 2022, then plunged by 68.76% to $11611.5 in 2023, then jumped by 103.5% to $23629.5 in 2024, then grew by 16.37% to $27498.1 in 2025, then rose by 5.52% to $29016.6 in 2026.
• The last three Current Leases figures came in at $29016.6 (Q1 2026), $27498.1 (Q4 2025), and $26831.0 (Q3 2025), per Business Quant data.